Avicins: A novel class of anti-myeloma agents

被引：0
|
作者：
Negri, J.
Mitsiades, N.
McMullan, C. J.
Hayden, P.
McMillin, D.
Klippel, S.
Tesmenitsky, Y.
Haridas, V.
Munshi, N.
Richardson, P.
Gutterman, J.
Anderson, K. C.
Mitsiades, C. S.
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Jerome Lipper Multiple Myeloma Ctr, Boston, MA USA
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：144 / 144
页数：1
相关论文
共 50 条
  • [1] Avicins: A novel class of anti-myeloma agents.
    Mitsiades, N
    McMullan, CJ
    Poulabi, V
    Negri, J
    Geer, DC
    Haridas, V
    Munshi, NC
    Gutterman, J
    Anderson, KC
    Mitsiades, CS
    [J]. BLOOD, 2004, 104 (11) : 929A - 929A
  • [2] Thiazolidinediones: A novel class of agents with anti-myeloma activity.
    Mitsiades, CS
    Mitsiades, N
    Poulaki, V
    Treon, SP
    Anderson, KC
    [J]. BLOOD, 2001, 98 (11) : 376A - 376A
  • [3] Novel anti-myeloma agents and angiogenesis
    Anargyrou, Konstantinos
    Dimopoulos, Meletios-Athanassios
    Sezer, Orhan
    Terpos, Evangelos
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (04) : 677 - 689
  • [4] The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma
    E Terpos
    M-A Dimopoulos
    O Sezer
    [J]. Leukemia, 2007, 21 : 1875 - 1884
  • [5] The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma
    Terpos, E.
    Dimopoulos, M-A
    Sezer, O.
    [J]. LEUKEMIA, 2007, 21 (09) : 1875 - 1884
  • [6] Novel Anti-Myeloma Agents and Bone Metabolism: Implications in the Management of Myeloma Bone Disease
    Terpos, Evangelos
    Christoulas, Dimitrios
    Kastritis, Efstathios
    Migkou, Magda
    Gavriatopoulou, Maria
    Dimopoulos, Meletios-Athanassios
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S30 - S32
  • [7] Modulation of cereblon levels by anti-myeloma agents
    Diaz-Rodriguez, Elena
    Pandiella, Atanasio
    [J]. LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 167 - 176
  • [8] Elotuzumab as a novel anti-myeloma immunotherapy
    Radhakrishnan, Sabarinath Venniyil
    Bhardwaj, Neelam
    Steinbach, Mary
    Weidner, Janet
    Luetkens, Tim
    Atanackovic, Djordje
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (08) : 1751 - 1757
  • [9] Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
    Jumpei Teramachi
    Hirokazu Miki
    Shingen Nakamura
    Masahiro Hiasa
    Takeshi Harada
    Masahiro Abe
    [J]. Journal of Bone and Mineral Metabolism, 2023, 41 : 388 - 403
  • [10] Small molecule MIRA-1 induces in vitro and in vivo anti-myeloma activity and synergizes with current anti-myeloma agents
    Saha, M. N.
    Chen, Y.
    Chen, M-H
    Chen, G.
    Chang, H.
    [J]. BRITISH JOURNAL OF CANCER, 2014, 110 (09) : 2224 - 2231
12345